Fentanyl Xylazine

“Fentanyl is the single deadliest drug threat our nation has ever encountered.  Fentanyl is everywhere.  From large metropolitan areas to rural America, no community is safe from this poison.  We must take every opportunity to spread the word to prevent fentanyl-related overdose death and poisonings from claiming scores of American lives every day.”                                     - DEA Administrator Anne Milgram

________________________________________________________________________________________________________________________________________________________________________________

Addiction to substances can affect individuals from all walks of life, regardless of age, gender, socioeconomic status, or background. There is no single factor that determines who may develop an addiction, as it is influenced by a combination of genetic, environmental, and psychological factors. Some common risk factors for addiction include:

  1. Genetics: Certain genetic factors can predispose individuals to addiction, making them more susceptible to the effects of drugs or alcohol.
  2. Trauma and Stress: Adverse childhood experiences, trauma, chronic stress, and mental health disorders can increase the risk of developing substance use disorder as a way of coping with emotional pain or distress.
  3. Social and Environmental Factors: Peer pressure, social norms surrounding substance use, exposure to drug use within the family or community, and lack of access to education and economic opportunities can all contribute to the development of addiction.
  4. Co-occurring Disorders: Substance use disorder often co-occurs with other mental health conditions such as depression, anxiety, bipolar disorder, or post-traumatic stress disorder (PTSD), further complicating the picture and making treatment more challenging.

Fentanyl and xylazine test strips are helpful tools for individuals who use substances, regardless of their background or circumstances. Here's why:

  1. Harm Reduction: Fentanyl and xylazine test strips provide a harm reduction approach to substance use, allowing individuals to make informed decisions about their consumption. By detecting the presence of these potent substances in drugs, users can take appropriate precautions to reduce the risk of overdose and other adverse effects.
  2. Prevention of Overdose: Fentanyl, in particular, has been implicated in a significant number of opioid-related overdose deaths due to its high potency. By identifying fentanyl in drugs before use, individuals can take steps to avoid accidental overdose and seek medical assistance if necessary.
  3. Empowerment: Test strips empower individuals who use substances to take control of their health and safety. They provide valuable information about the contents of drugs, enabling users to make choices that align with their personal risk tolerance and harm reduction goals.
  4. Accessibility: Fentanyl and xylazine test strips are relatively easy to use and are becoming increasingly accessible through harm reduction organizations, community health centers, and online retailers. Their affordability and availability make them valuable tools for individuals seeking to minimize the risks associated with substance use.

In summary, fentanyl and xylazine test strips play a crucial role in harm reduction efforts by providing individuals who use substances with the means to identify potentially dangerous substances and reduce the risk of overdose and other adverse effects. By promoting informed decision-making and empowering users to prioritize their health and safety, these test strips contribute to the overall well-being of individuals and communities affected by substance use disorder.

What is Fentanyl? NIDA  has information.  

 

*****Xylazine Test Strips Instruction for use*****

  • Fact:  There are over 23.5 million people in long-term recovery in the U.S. from a substance use disorder. People do recover and get well.
  • Fact:  Adolescents experience less health risks when their parents know about what is going on with them and their lives (CDC-April 2023)
  • Fact:  DEA National RX Take Back Day reported 599,897 lbs (300 tons) of Prescription drugs collected in Michigan on October 2023 with 4675 Collections sites now In Michigan.
  • Fact:  730,000+ naloxone kits and recorded over 6,600 overdose reversals since the 2020 launch of Michigan’s Portal, at no charge
  • Fact:  Xylazine is a potent veterinary tranquilizer/sedative never approved for human use but increasingly found in the illicit drug supply and frequently used along with fentanyl.(michigan.gov)
Find out how to get help now

Contact Us / Send Feedback